Health Canada Grants DEL Amendment for Expanded Psilocybin Analogs

PRINCETON, BC — Optimi Health Corp. (CSE: OPTI · OTCQX: OPTHF) today announced that Health Canada has granted an amendment to the Company's Controlled Drugs and Substances Dealer's Licence (DEL) permitting the manufacture and distribution of an expanded set of psilocybin analogs for use in regulated access programs and approved clinical research.